PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.\', \'China National Biotec Group Company Limited, Beijing, China.\', \'Henan Province Center for Disease Control and Prevention, Zhengzhou, Henan, China.\', \'Bahrain Defence Force Royal Medical Services, Military Hospital, Kingdom of Bahrain.\', \'Ministry of Health and Prevention, Abu Dhabi, United Arab Emirates.\', \'Prince Hamza Hospital, Amman, Jordan.\', \'Ministry of Health, Cairo, Egypt.\', \'Ministry of Health, Kingdom of Bahrain.\', \'National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co, Ltd, Wuhan, Hubei, China.\', \'Beijing Institute of Biological Products Co, Ltd, Beijing, China.\', \'Beijing Key-Tech Statistical Consulting Co, Ltd, Beijing, China.\', \'Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.\', \'G42 Healthcare, Abu Dhabi, United Arab Emirates.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jama.2021.8565
?:doi
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 34037666
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all